沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
沃森生物(300142) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入143,334.8659,975.36411,377.23315,804.44216,767.13
营业收入143,334.8659,975.36411,377.23315,804.44216,767.13
二、营业总成本117,865.5646,214.98315,221.33232,086.84152,614.44
营业成本28,672.8311,351.8859,755.6245,126.3627,256.67
营业税金及附加934.38417.343,202.602,537.271,971.25
销售费用50,021.8021,045.57151,957.55114,335.2478,304.65
管理费用12,316.846,178.5629,762.3718,062.6512,089.54
财务费用-2,776.53-1,480.44-7,099.33-5,318.92-3,526.25
研发费用28,696.258,702.0677,642.5357,344.2336,518.59
资产减值损失----------
公允价值变动收益-10,200.98-8,481.79-23,475.01-6,738.89-1,765.29
投资收益365.448.68711.45629.46632.84
其中:对联营企业和合营企业的投资收益0.138.6838.21-43.78-40.40
汇兑收益----------
三、营业利润18,841.675,964.9261,396.6177,931.1663,205.55
加:营业外收入12,692.410.0193.5193.3291.32
减:营业外支出3,764.75239.601,592.47602.38494.49
其中:非流动资产处置损失----------
四、利润总额27,769.325,725.3259,897.6577,422.1162,802.38
减:所得税费用2,017.711,894.108,765.147,699.176,547.46
五、净利润25,751.613,831.2251,132.5169,722.9456,254.91
归属于母公司所有者的净利润17,056.051,412.7541,939.0255,337.6545,523.98
少数股东损益8,695.572,418.479,193.4914,385.2910,730.93
六、每股收益
基本每股收益(元/股)0.10660.00880.26210.34580.2844
稀释每股收益(元/股)0.10660.00880.26210.34580.2844
七、其他综合收益----------
八、综合收益总额25,751.613,831.2251,132.5169,722.9456,254.91
归属于母公司所有者的综合收益总额17,056.051,412.7541,939.0255,337.6545,523.98
归属于少数股东的综合收益总额8,695.572,418.479,193.4914,385.2910,730.93
下载全部历史数据到excel中 返回页顶